- Home
- HUBB vs ILMN Comparison
HUBB vs ILMN Comparison
Compare HUBB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- ILMN
- Stock Information
- Founded
- HUBB 1888
- ILMN 1998
- Country
- HUBB United States
- ILMN United States
- Employees
- HUBB N/A
- ILMN N/A
- Industry
- HUBB Industrial Machinery/Components
- ILMN Medical Specialities
- Sector
- HUBB Technology
- ILMN Health Care
- Exchange
- HUBB Nasdaq
- ILMN Nasdaq
- Market Cap
- HUBB 23.2B
- ILMN 16.0B
- IPO Year
- HUBB N/A
- ILMN 2000
- Fundamental
- Price
- HUBB $438.39
- ILMN $100.92
- Analyst Decision
- HUBB Buy
- ILMN Buy
- Analyst Count
- HUBB 8
- ILMN 15
- Target Price
- HUBB $472.63
- ILMN $123.67
- AVG Volume (30 Days)
- HUBB 437.6K
- ILMN 1.3M
- Earning Date
- HUBB 10-28-2025
- ILMN 11-03-2025
- Dividend Yield
- HUBB 1.21%
- ILMN N/A
- EPS Growth
- HUBB 14.86
- ILMN N/A
- EPS
- HUBB 15.40
- ILMN 7.91
- Revenue
- HUBB $5,626,400,000.00
- ILMN $4,284,000,000.00
- Revenue This Year
- HUBB $6.67
- ILMN N/A
- Revenue Next Year
- HUBB $5.71
- ILMN $2.76
- P/E Ratio
- HUBB $28.44
- ILMN $12.64
- Revenue Growth
- HUBB 0.95
- ILMN N/A
- 52 Week Low
- HUBB $299.43
- ILMN $68.70
- 52 Week High
- HUBB $481.35
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- HUBB 52.49
- ILMN 54.31
- Support Level
- HUBB $427.85
- ILMN $95.12
- Resistance Level
- HUBB $453.20
- ILMN $99.56
- Average True Range (ATR)
- HUBB 10.18
- ILMN 3.05
- MACD
- HUBB -0.11
- ILMN -0.04
- Stochastic Oscillator
- HUBB 52.32
- ILMN 98.73
About HUBB Hubbell Inc
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, electrical substations, and within commercial and industrial buildings. The company's primary operations are within the United States, where around 90% of revenue is derived.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.